Biotech startup lands $57M to map new routes for tripping up cancer


"At the end of the day, someone's got to do it," said Cartography Biosciences CEO Kevin Parker.

Previous Elon Musk is now just one of two founding team members left at brain implant developer Neuralink
Next SA health company makes C-suite move amid 'explosive' growth